|
Volumn 82, Issue 1, 1995, Pages 79-82
|
Prospective randomized study of surgical morbidity following primary systemic therapy for breast cancer
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
GOSERELIN;
TAMOXIFEN;
ADULT;
ARTICLE;
BREAST CANCER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MASTECTOMY;
MORBIDITY;
OBESITY;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
LENGTH OF STAY;
LOGISTIC MODELS;
MASTECTOMY, RADICAL;
MIDDLE AGED;
MORBIDITY;
PROSPECTIVE STUDIES;
RISK FACTORS;
|
EID: 0028799631
PISSN: 00071323
EISSN: 13652168
Source Type: Journal
DOI: 10.1002/bjs.1800820127 Document Type: Article |
Times cited : (51)
|
References (38)
|